Industry reports
Editor highlights

Drug and Medication Industry Market Research Reports in France, April 2014

You might be interested in: drug, vaccine, medicine, more »

» View Public Reports

1-33 of 56 reports

Emergency Contraception in France

  • Industry report
  • June 2013
  • 3 pages

The Emergency Contraception in France CapsuleĀ provides headlines, market sizeĀ and competitive analysis alongside a set of charts including company shares, national brand own...

  • Industries: Drug and Medication
  • Countries: France

Investor presentation: Drug and Medication in China and Europe for Year 2013

  • Company report
  • October 2013
  • 34 pages

... Phase iii functioning net (us) spasticity ph iii in adult upper limb (us) dysport next generation ph iii in cervical dystonia (europe) tasquinimod ph iii in mcrpc (ww excl.Us and japan ...

  • Industries: Drug and Medication
  • Countries: France, China, Europe

Drug and Medication Sector in France

  • Industry report
  • June 2013
  • 20 pages

... Network and the complexity of the french distribution system. Other products medical devices, food supplements, cosmetics, hygiene and dietetic products such as vi- tamins and/or minerals ...

  • Industries: Drug and Medication
  • Countries: France

The French Drug and Medication Business

  • Industry report
  • May 2013
  • 7 pages
  • by Intergovernmental Agency

... Materials From the who- gisrs, such as influenza vaccine, diagnostic and pharmaceutical manufactus, as well as biotechnology firms, research institutions and academic institutions. The pip framework ...

  • Industries: Drug and Medication
  • Countries: France

The European Drug and Medication : Industry Overview and Key Players

  • Industry report
  • March 2013
  • 37 pages

... Regulations regarding the import of investigational or pre-launch medications for cu 9 compassionate use programmes National programmes differ due to differences in: National medical practices ...

  • Industries: Drug and Medication
  • Countries: France, Europe, United Kingdom

Drug Sector in France

  • Industry report
  • March 2013
  • 44 pages

... And over 64% report that besides the information provided by their doctor or pharmacist, they look for additional information on the medication they are taking 48% on the information leaflet ...

  • Industries: Drug and Medication
  • Countries: France

Investor presentation: Drug and Medication in The United States, France and China for Year 2013

  • Company report
  • March 2013
  • 33 pages
  • Industries: Drug and Medication
  • Countries: United States, France, China

Investor presentation: Drug and Medication in France and The United States for Year 2013

  • Company report
  • March 2013
  • 35 pages
  • Industries: Drug and Medication
  • Countries: World, France, United States

Drug and Medication Production and Trade Statistics in The United States and France

  • Industry report
  • December 2012
  • 25 pages

... Endocarditis, a stringent model 73 with long-standing records for evaluation of antibacterial agents, which demonstrated its 74 capacity to predict clinical efficacy in humans, and to discriminate ...

  • Industries: Drug and Medication
  • Countries: United States, France

The French Antibiotic Industry Analysis

  • Industry report
  • October 2012
  • 104 pages

... Data on the intestinal microflora as well as the results of the bioassays for antibiotic concentrations in faecal samples, telavancin has a favourable ecological profile. Antimicrobial resistance ...

  • Industries: Drug and Medication
  • Countries: France

Company Report: Drug and Medication in France for Year 2012

  • Company report
  • September 2012
  • 2 pages

... Needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health ...

  • Industries: Drug and Medication
  • Countries: France

Company Report: Drug and Medication in The United States and France for Year 2012

  • Company report
  • September 2012
  • 9 pages
  • by Corporation
  • Industries: Drug and Medication
  • Countries: United States, France

Vaccine Market in The United States and France

  • Industry report
  • September 2012
  • 33 pages

... Trivalent inactivated influenza vaccine (tiv) 4. Tetanus and reduced diphtheria toxoids and acellular pertussis (tdap) 5. Meningococcal conjugate vaccine (quadrivalent) (mcv4) 6. Hepatitis a vaccine ...

  • Industries: Drug and Medication
  • Countries: United States, France

Company Report: Drug and Medication in France and The United States for Year 2012

  • Company report
  • July 2012
  • 2 pages

... And development, future clinical data and analysis, including post marketing, s by regulatory authorities, such as the fda or the ema, regarding whether and when to approve any drug, device or biological ...

  • Industries: Drug and Medication
  • Countries: France, United States

The French Drug and Medication Industry

  • Industry report
  • May 2012
  • 38 pages
  • Industries: Drug and Medication
  • Countries: France

Investor presentation: Drug and Medication in France and The United States for Year 2012

  • Company report
  • April 2012
  • 32 pages

... Early stage pipeline jefferies 2012 global healthcare conference 2013 / 2014 update tasquinimod mcrpc phiii results end 2013 dysport next generation top line results + stability 2013 dysport ...

  • Industries: Drug and Medication
  • Countries: World, France, United States

Investor presentation: Drug and Medication in France for Year 2012

  • Company report
  • March 2012
  • 36 pages

... In full. Finally, in those countries in which public or private health cover is provided, the impact of the financial crisis could cause medical insurance agencies to place added pressure on drug prices ...

  • Industries: Drug and Medication
  • Countries: France

Investor presentation: Drug and Medication in Europe and China for Year 2012

  • Company report
  • March 2012
  • 34 pages

... In adult upper limb (us) dysport next generation ph iii in cervical dystonia (europe) tasquinimod ph iii in mcrpc (ww excl.Us and japan) clarinet ph iii gep-net antitumor effect (ww) somatuline ...

  • Industries: Drug and Medication
  • Countries: Europe, France, China

Investor presentation: Drug and Medication in Europe and China for Year 2012

  • Company report
  • March 2012
  • 34 pages
  • Industries: Drug and Medication
  • Countries: Europe, France, China

Investor presentation: Drug and Medication in Europe and China for Year 2012

  • Company report
  • March 2012
  • 34 pages
  • Industries: Drug and Medication
  • Countries: Europe, France, China

Investor presentation: Drug and Medication for Year 2012

  • Company report
  • March 2012
  • 40 pages

... Medical insurance agencies to place added pressure on drug prices, increase financial contributions by patients or adopt a more selective approach to reimbursement criteria. All of the above risks could ...

  • Industries: Drug and Medication
  • Countries: World, France, Europe

Ipsen S.A. - Annual Report 2012

  • Company report
  • February 2012
  • 33 pages

... Patient basis "atu"). Other measures announced by the minister for work, employment and health but not in this bill, should also be decided, such as a new tax for drug companies to fund continuing medical ...

  • Industries: Drug and Medication
  • Countries: France, United States, Europe

Company Report: Drug and Medication in The United States and Europe for Year 2012

  • Company report
  • January 2012
  • 2 pages

... The world, represents groundbreaking and life-saving advances in medicine. As a sanofi company, genzyme benefits from the reach and resources of one of the world S largest pharmaceutical companies ...

  • Industries: Drug and Medication
  • Countries: United States, France, Europe

Company Report: Drug in India, Singapore and France for Year 2012

  • Company report
  • January 2012
  • 2 pages
  • Industries: Drug and Medication
  • Countries: India, Singapore, France

Medicine Sector in Europe

  • Industry report
  • December 2011
  • 20 pages

... Part i Drug packaging and children: prescrire S overview of the situation as of 2011 far too often, the packaging of paediatric medicines creates a risk of medication errors and far too many ...

  • Industries: Drug and Medication
  • Countries: Europe, France

Antibiotic Sector Analysis in Argentina and France

  • Industry report
  • November 2011
  • 71 pages

... Too Drugs has influence on antibiotic consumption; 27 generics for antibiotics (quinolones) : conclusions more generics/ Me too Decrease relative price increase antibiotic consumption (not true for all ...

  • Industries: Drug and Medication
  • Countries: Argentina, France

Company Report: Drug and Medication for Year 2011

  • Company report
  • November 2011
  • 65 pages

... To which amc implementation is as planned and whether the complementary activities to support the introduction and demand of conjugate vaccines are occurring. Impact studies will be conducted every 4 ...

  • Industries: Drug and Medication
  • Countries: France, World, Europe

Brazil and Europe: Brief Overview, 2011, focus on Drug and Medication

  • Country report
  • October 2011
  • 2 pages

... Injection, enabling perfect treatment compliance, and very swift action. The new anti-infective complies with the latest health authority requirements concerning the correct use of antibiotics as well ...

  • Industries: Drug and Medication
  • Countries: Brazil, France, Europe

Investor presentation: Drug and Medication in The United States and Europe for Year 2011

  • Company report
  • April 2011
  • 40 pages

... Financial equilibrium is threatened by the crisis and where the group sells its drugs directly to hospitals, the group could be forced to lengthen its payment terms or could experience difficulties ...

  • Industries: Drug and Medication
  • Countries: United States, France, Europe

Investor presentation: Drug and Medication in France for Year 2011

  • Company report
  • March 2011
  • 38 pages

... In full. Finally, in those countries in which public or private health cover is provided, the impact of the financial crisis could cause medical insurance agencies to place added pressure on drug prices ...

  • Industries: Drug and Medication
  • Countries: France

Company Report: Vaccine in The United States and Europe for Year 2011

  • Company report
  • March 2011
  • 2 pages
  • by Corporation

... Stage clinical development. Unchanged outlook for 2012 for the 2012 financial year, alk expects growth in vaccines sales of 3-5% and total revenue of up to dkk 2.4 Billion. Despite a record-high activity level ...

  • Industries: Drug and Medication
  • Countries: France, United States, Europe

» Purchase Premium Reports (From $ 300 - $ 6 995)

About 100 reports
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic ...

France Vaccine Exports, Eurmn

January 2013 $ 250

France Vaccine Imports, Eurmn

January 2013 $ 250

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.